Clinical trials with IL-2.
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004995:Ethics, Professional; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*; D009732:Nursing Care; D011994:Recombinant Proteins / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins